Neurostimulation Devices Companies

ID: MRFR/MED/1663-HCR

200 Pages

Satyendra Maurya

Last Updated: February 16, 2025

At the forefront of neurological innovation, Neurostimulation Devices companies specialize in creating cutting-edge technologies. Their expertise lies in developing implantable and non-invasive devices that employ neurostimulation techniques. These advancements offer therapeutic solutions for conditions such as chronic pain, epilepsy, and movement disorders, providing new avenues for patient care.

Neurostimulation Devices Market

Market Size

Forecast Period2026-2035

CAGR (2026-2035)11.50%

2025 Market SizeUSD 9.98 Billion

2035 Market SizeUSD 29.72 Billion

Key Players

Medtronic plc

Boston Scientific Corp.

Abbott Laboratories

Nevro Corp.

LivaNova plc

ElectroCore Inc.

Trends

Rising Neurological Disease Prevalence
Closed-Loop and AI-Enabled Device Innovation
Expanded Reimbursement for Neuromodulation Treatment

Opportunities

Non-Invasive Neurostimulation Platforms
Emerging Market Hospital Expansion
Closed-Loop Data Monetization and Digital Biomarkers

Summary Table of Contents Segmentation Methodology Download PDF

Customize Report

Certified Researchers

Top Industry Leaders in the Neurostimulation Devices Market

Latest Neurostimulation Devices Companies Update

Boston Scientific acquires NeuroPace for $825 million deal strengthens Boston Scientific's position in the deep brain stimulation (DBS) market, giving them access to NeuroPace's novel RNS® system for epilepsy treatment.

Abbott acquires St. Jude Medical for $30 billion mega-deal expands Abbott's reach in the spinal cord stimulation (SCS) market, adding St. Jude Medical's innovative portfolio of SCS devices to their offerings.

on-invasive brain stimulation for mental health Research is exploring the use of transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) for treating conditions like depression and anxiety, offering less invasive alternatives to traditional therapy.

Bioresorbable neurostimulation devices Companies like NeuroPace are developing implants that dissolve over time, potentially reducing risks associated with permanent implant removal.

List of Neurostimulation Devices Key Companies in the Market

Nevro Corporation
NeuroPace
ImThera Medical
Therapeutics
LivaNova (Cyberonics)
SPR Therapeutics
Autonomic Technologies
ElectroCore
NeuroSigma
Neuros Medical
Jude Medical
Neurometrix
Synapse Biomedical
Boston Scientific
BioControl Medical
Soterix Medical
Helius Medical
Abbott
GiMer Medical
BlueWind
Neuronano
Bioindduction
MicroTransponder

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”